Teva Pharmaceutical Industries Ltd. (TEVA)
38.10
+1.17
(+3.17%)
USD |
NYSE |
Aug 25, 16:00
37.97
-0.13
(-0.34%)
After-Hours: 19:59
Teva Pharmaceutical Industries EPS Diluted (Quarterly) : -0.5029 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5029 |
| March 31, 2026 | 0.3121 |
| December 31, 2025 | 0.4118 |
| September 30, 2025 | 0.3737 |
| June 30, 2025 | 0.2481 |
| March 31, 2025 | 0.1846 |
| December 31, 2024 | -0.1931 |
| September 30, 2024 | -0.3857 |
| June 30, 2024 | -0.7467 |
| March 31, 2024 | -0.1238 |
| December 31, 2023 | 0.4054 |
| September 30, 2023 | 0.0606 |
| June 30, 2023 | -0.7694 |
| March 31, 2023 | -0.1955 |
| December 31, 2022 | -1.168 |
| September 30, 2022 | 0.05 |
| June 30, 2022 | -0.209 |
| March 31, 2022 | -0.8627 |
| December 31, 2021 | -0.1441 |
| September 30, 2021 | 0.2633 |
| June 30, 2021 | 0.1866 |
| March 31, 2021 | 0.0696 |
| December 31, 2020 | 0.1364 |
| September 30, 2020 | -3.968 |
| June 30, 2020 | 0.1273 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.063 |
| December 31, 2019 | 0.1005 |
| September 30, 2019 | -0.2895 |
| June 30, 2019 | -0.6302 |
| March 31, 2019 | -0.0967 |
| December 31, 2018 | -2.832 |
| September 30, 2018 | -0.2682 |
| June 30, 2018 | -0.2348 |
| March 31, 2018 | 1.033 |
| December 31, 2017 | -11.46 |
| September 30, 2017 | 0.5215 |
| June 30, 2017 | -6.000 |
| March 31, 2017 | 0.578 |
| December 31, 2016 | -1.02 |
| September 30, 2016 | 0.35 |
| June 30, 2016 | 0.20 |
| March 31, 2016 | 0.62 |
| December 31, 2015 | 0.55 |
| September 30, 2015 | 0.12 |
| June 30, 2015 | 0.63 |
| March 31, 2015 | 0.52 |
| December 31, 2014 | 0.80 |
| September 30, 2014 | 1.02 |
| June 30, 2014 | 0.87 |
| March 31, 2014 | 0.87 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
| Bristol Myers Squibb Co. | 1.620 |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -0.5737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -585.89M |
| Revenue (Quarterly) | 4.221B |
| Total Expenses (Quarterly) | 4.807B |
| Enterprise Value | 57.61B |
| Gross Profit Margin (Quarterly) | 52.07% |
| Profit Margin (Quarterly) | -13.88% |
| Earnings Yield | 1.56% |
| Operating Earnings Yield | 7.35% |
| Normalized Earnings Yield | 4.166 |